Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.
1. The Maharashtra Food and Drug Administration has prohibited the sale, distribution and use of three skin-lightening creams after detecting dangerously high levels of mercury and lead, along with labelling violations. The action underscores stricter enforcement of safety and labelling requirements under the Drugs and Cosmetics Act, 1940 and the Cosmetics Rules, 2020.
Source: short-url.cc/1tgYn
2. India’s Rajasthan government has reportedly introduced a three-tier drug quality testing mechanism for medicines procured under the state’s public healthcare system due to concerns about drug quality. The enhanced measures require quality verification at multiple stages, enhanced oversight by healthcare institutions, and stricter monitoring of medicines and surgical consumables. The state has also expanded its investigation into the concerned drug manufacturer while strengthening procurement and quality assurance processes.
Source: short-url.cc/1tgWb
3. India’s Central Drug Authority, CDSCO has reportedly signed a memorandum of understanding (MoU) with Indonesia’s National Agency of Drug and Food Control (NADFC). The partnership aims to improve cooperation in regulating pharmaceuticals and medical products. The agreement allows for sharing regulatory information, technical skills, and best practices. The agreement seeks to benefit manufacturers by creating a predictable regulatory environment and enhancing international trade.
Source: short-url.cc/1yNWW
4. India’s Telangana government is set to enforce stricter regulations for private In-Vitro Fertilisation (IVF) centres to improve transparency, curb unethical practices and strengthen oversight of Assisted Reproductive Technology (ART) services. The proposed measures include frequent inspections and monitoring of licensing, medicines, record maintenance, and stricter compliance with the Assisted Reproductive Technology (Regulation) Act, 2021, and the Surrogacy (Regulation) Act, 2021.
Source: short-url.cc/1tgWl
5. The Indian Medical Association (IMA) has opposed the Maharashtra Clinical Establishments (Registration and Regulation) Bill, expressing adverse effects on the functioning of private medical establishments by imposing excessive regulations and limiting autonomy. The association has urged the state government to reconsider the draft legislation and has warned of a statewide strike and boycott of government healthcare schemes if its concerns are not addressed.
Source: short-url.cc/1tgWq